Waukegan, IL, United States of America

David J Grampovnik

This inventor holds 19 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Antiviral Compounds. Top assignees: Abbott Laboratories Corporation, Abbvie Inc., Enanta Pharmaceuticals, Inc.. Active years: 1980-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Grampovnik. Retrieved from https://idiyas.com/inventor/david-j-grampovnik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 63.2

 

 

Average Co-Inventor Count = 8.7

ph-index = 5

Forward Citations = 118(Granted Patents)


Location History:

  • North Chicago, IL (US) (1980)
  • Waukegan, IN (US) (2015)
  • Waukegan, IL (US) (1997 - 2016)

Company Filing History:


Years Active: 1980-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Aryl Substituted
Pyrazolyl Enones
Hepatitis C Inhibitors
HIV Protease Inhibitors
Macrocyclic Compounds
Neuraminidase Inhibitors
Prodrugs
Amino-Lipopetide
Antifungal Agents
Inflammation Modulators
Anti-Viral Compounds
19 patents (USPTO):Explore Patents

Title: A Closer Look at David J Grampovnik: Pioneering Innovator in Biomedical Research

Introduction: David J Grampovnik, a distinguished inventor based in Waukegan, IL, has left an indelible mark in the field of biomedical research with his groundbreaking innovations and numerous patents.

Latest Patents: Grampovnik's recent patents highlight his expertise in developing cutting-edge solutions for treating diseases associated with oxidative stress and inflammation. His inventions include compounds such as aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators, as well as macrocyclic hepatitis C serine protease inhibitors.

Career Highlights: With an impressive portfolio of 19 patents, Grampovnik has revolutionized the healthcare industry with his novel approaches to drug development. Having worked at esteemed companies like Abbott Laboratories and AbbVie Inc., he has demonstrated a keen understanding of pharmaceutical research and development.

Collaborations: Throughout his career, Grampovnik has collaborated closely with accomplished professionals in the field, including coworkers such as Dale J Kempf and Hui-Ju J Chen. These collaborations have been instrumental in advancing his innovative research initiatives and bringing his inventions to fruition.

Conclusion: David J Grampovnik's contributions to biomedical research underscore his commitment to advancing medical science and improving patient outcomes. His inventive spirit and collaborative approach continue to inspire the next generation of innovators in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…